Cargando…

An independent and external validation of QRISK2 cardiovascular disease risk score: a prospective open cohort study

Objective To evaluate the performance of the QRISK2 score for predicting 10-year cardiovascular disease in an independent UK cohort of patients from general practice records and to compare it with the NICE version of the Framingham equation and QRISK1. Design Prospective cohort study to validate a c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Collins, Gary S, Altman, Douglas G
Formato:	Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group Ltd. 2010
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2869403/ https://www.ncbi.nlm.nih.gov/pubmed/20466793 http://dx.doi.org/10.1136/bmj.c2442

Ejemplares similares

An independent external validation and evaluation of QRISK cardiovascular risk prediction: a prospective open cohort study
por: Collins, Gary S, et al.
Publicado: (2009)

Predicting the 10 year risk of cardiovascular disease in the United Kingdom: independent and external validation of an updated version of QRISK2
por: Collins, Gary S, et al.
Publicado: (2012)

Independent external validation of the QRISK3 cardiovascular disease risk prediction model using UK Biobank
por: Parsons, Ruth E, et al.
Publicado: (2023)

Predicting risk of osteoporotic and hip fracture in the United Kingdom: prospective independent and external validation of QFractureScores
por: Collins, Gary S, et al.
Publicado: (2011)

Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study
por: Hippisley-Cox, Julia, et al.
Publicado: (2017)

Cardiovascular risk quantification using QRISK-3 score in people with intellectual disability
por: Ho, Jamie Sin Ying, et al.
Publicado: (2021)

Effect of competing mortality risks on predictive performance of the QRISK3 cardiovascular risk prediction tool in older people and those with comorbidity: external validation population cohort study
por: Livingstone, Shona, et al.
Publicado: (2021)

Assessing the validity of QRISK3 in predicting cardiovascular events in systemic lupus erythematosus
por: Zhu, Lisa, et al.
Publicado: (2022)

QRISK3 Performance in the Assessment of Cardiovascular Risk in Patients with Inflammatory Bowel Disease
por: Carrillo-Palau, Marta, et al.
Publicado: (2021)

Derivation, validation, and evaluation of a new QRISK model to estimate lifetime risk of cardiovascular disease: cohort study using QResearch database
por: Hippisley-Cox, Julia, et al.
Publicado: (2010)

QRISK3 improves detection of cardiovascular disease risk in patients with systemic lupus erythematosus
por: Edwards, Nicola, et al.
Publicado: (2018)

Ethnicity and prediction of cardiovascular disease: performance of QRISK2 and Framingham scores in a UK tri-ethnic prospective cohort study (SABRE—Southall And Brent REvisited)
por: Tillin, Therese, et al.
Publicado: (2013)

Assessment of QRISK3 as a predictor of cardiovascular disease events in type 2 diabetes mellitus
por: Mu, Xiaodie, et al.
Publicado: (2022)

Sample size considerations for the external validation of a multivariable prognostic model: a resampling study
por: Collins, Gary S., et al.
Publicado: (2015)

Predictive performance of a competing risk cardiovascular prediction tool CRISK compared to QRISK3 in older people and those with comorbidity: population cohort study
por: Livingstone, Shona J., et al.
Publicado: (2022)

Prediction of Cardiovascular Risk Using Framingham, ASSIGN and QRISK2: How Well Do They Predict Individual Rather than Population Risk?
por: van Staa, Tjeerd-Pieter, et al.
Publicado: (2014)

Quantitative examination of video-recorded NHS Health Checks: comparison of the use of QRISK2 versus JBS3 cardiovascular risk calculators
por: Gidlow, Christopher J, et al.
Publicado: (2020)

Predictive role of novel echocardiographic parameter aortic velocity propagation, QRISK3 and Framingham risk score for presence and severity of CAD in Asian patients
por: Vyas, Pooja, et al.
Publicado: (2022)

Independent external validation of cardiovascular disease mortality in women utilising Framingham and SCORE risk models: a mortality follow-up study
por: Goh, Louise Gek Huang, et al.
Publicado: (2014)

Performance of risk prediction scores for cardiovascular mortality in older persons: External validation of the SCORE OP and appraisal
por: Piccininni, Marco, et al.
Publicado: (2020)

Subclinical parameters of arterial stiffness and arteriosclerosis correlate with QRISK3 in systemic lupus erythematosus
por: Vázquez-Del Mercado, Mónica, et al.
Publicado: (2018)

The effect of long-acting injectable antipsychotics on QRISK3 in patients with bipolar disorder and schizophrenia
por: Erbasan, V., et al.
Publicado: (2023)

Correction: Performance of risk prediction scores for cardiovascular mortality in older persons: External validation of the SCORE OP and appraisal
por: Piccininni, Marco, et al.
Publicado: (2020)

External validation of the QLifetime cardiovascular risk prediction tool: population cohort study
por: Livingstone, Shona, et al.
Publicado: (2023)

Modified cardiovascular SOFA score in sepsis: development and internal and external validation
por: Lee, Hui Jai, et al.
Publicado: (2022)

External validation of a Cox prognostic model: principles and methods
por: Royston, Patrick, et al.
Publicado: (2013)

External validation of the ACC/AHA ASCVD risk score in a Colombian population cohort
por: Rodríguez-Ariza, Carlos Daniel, et al.
Publicado: (2023)

Assessment of Cardiovascular Disease Risk in Adults With Severe Mental Illness Admitted to Acute Psychiatric Unit Using QRISK-3 Assessment Tool: A Quality Improvement Project
por: Elbadrmany, Ibrahim, et al.
Publicado: (2023)

Performance of the Expanded Cardiovascular Risk Prediction Score for Rheumatoid Arthritis in a geographically distant National Register-based cohort: an external validation
por: Ljung, Lotta, et al.
Publicado: (2018)

External validation of the Hospital Frailty Risk Score in France
por: Gilbert, Thomas, et al.
Publicado: (2021)

External validation of the REMEMBER score
por: Peivandi, Armin Darius, et al.
Publicado: (2023)

Correction: Modified cardiovascular SOFA score in sepsis: development and internal and external validation
por: Lee, Hui Jai, et al.
Publicado: (2022)

Derivation and validation of QStroke score for predicting risk of ischaemic stroke in primary care and comparison with other risk scores: a prospective open cohort study
por: Hippisley-Cox, Julia, et al.
Publicado: (2013)

Predictors for independent external validation of cardiovascular risk clinical prediction rules: Cox proportional hazards regression analyses
por: Ban, Jong-Wook, et al.
Publicado: (2018)

Identifying patients with undetected colorectal cancer: an independent validation of QCancer (Colorectal)
por: Collins, G S, et al.
Publicado: (2012)

External validation and clinical usefulness of three commonly used cardiovascular risk prediction scores in an Emirati population: a retrospective longitudinal cohort study
por: Al-Shamsi, Saif, et al.
Publicado: (2020)

Independent evaluation of melanoma polygenic risk scores in UK and Australian prospective cohorts
por: Steinberg, Julia, et al.
Publicado: (2022)

The performance of seven QPrediction risk scores in an independent external sample of patients from general practice: a validation study
por: Hippisley-Cox, Julia, et al.
Publicado: (2014)

Independent External Validation of FRAX and Garvan Fracture Risk Calculators: A Sub‐Study of the FRISBEE Cohort
por: Baleanu, Felicia, et al.
Publicado: (2021)

External validation of a prehospital risk score for critical illness
por: Kievlan, Daniel R., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_htnj70e4ko4fn53defkddg7eeo